SCHEMBL1633110

SCHEMBL1633110

NS(=O)(=O)c1ccc(Nc2ncc3cc(F)cc(-c4ccc5c(c4)CCNC5=O)c3n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 13/20 0.47
CCNT1 O60563 2/20 0.45
CDK2 P24941 2/20 0.45
CDK9 P50750 2/20 0.45
CDK4 P11802 1/20 0.45
CCNA2 P20248 1/20 0.45
CCND1 P24385 1/20 0.45
CCND3 P30281 1/20 0.45
CDK7 P50613 1/20 0.45
CCNH P51946 1/20 0.45
MNAT1 P51948 1/20 0.45
CDK6 Q00534 1/20 0.45
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA4 P22748 2/20 0.44
CA9 Q16790 2/20 0.44
PIM1 P11309 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
PARP10 Q53GL7 1/20 0.42
PARP11 Q9NR21 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633494 0.89 PIM1 (0.54) IKBKBCA1CA2CA4CA9
SCHEMBL1632840 0.85 IKBKB (0.48) IKBKBCCNT1CDK2CDK9CDK4
SCHEMBL1633082 0.81 IKBKB (0.45) IKBKBCCNT1CDK2CDK9CDK4
SCHEMBL1632804 0.78 NTRK1 (0.48) IKBKBCCNT1CDK2CDK9CCNA2
SCHEMBL13498293 0.78 IKBKB (0.41) IKBKBCCNT1CDK2CDK9CDK4
SCHEMBL1632747 0.77 CA1 (0.41) IKBKBCCNT1CDK2CDK9CDK4
SCHEMBL1633663 0.77 NTRK1 (0.47) IKBKBCCNT1CDK2CDK9CCNA2
SCHEMBL1632659 0.76 CA1 (0.47) IKBKBCCNT1CDK2CDK9CA1
SCHEMBL1474734 0.76 AURKA (0.52) IKBKBCCNT1CDK2CDK9CDK4
SCHEMBL1632130 0.76 SYK (0.47) IKBKBCCNT1CDK2CDK9CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed